Chair: John Scott
Targeting CAMKK2 for the treatment of advanced prostate cancer (#11)
9:00 AM
CaMKK2: at the interface of nutrient sensing and cancer cell progression (#12)
9:30 AM
Defining novel AMPK substrates by lysosome-enriched phosphoproteomics (#13)
9:50 AM